Tissue-specific expression of the human brain natriuretic peptide gene in cardiac myocytes

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 715-722

  LaPointe, Margot C ^a   Wu, Guiyun ^a   Garami, Miklós ^b   Yang, Xiao Ping ^a   Gardner, David G ^b  

^a HENRY FORD HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

gene regulation; heart cells; natriuretic factor, brain; peptides

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; GENE CONTROL; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HYPERTENSION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0029865084     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.715     Document Type: Conference Paper

References (26)

1. Ogawa Y, Itch H, Nakao K. Molecular biology and biochemistry of natriuretic peptide family. Clin Exp Pharmacol Physiol. 1995;22: 49-53.
2. Ogawa Y, Nakao K. Brain natriuretic peptide as a cardiac hormone in cardiovascular disorders. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. New York, NY: Raven Press Publishers; 1995:833-840.
3. LaPointe MC, Sitkins JR. Phorbol ester stimulates the synthesis and secretion of brain natriuretic peptide from neonatal rat ventricular cardiocytes: a comparison with the regulation of atrial natriuretic factor. Mol Endocrinol. 1993;7:1284-1296.
4. Dagino L, Drouin J, Nemer M. Differential expression of natriuretic peptide genes in cardiac and extracardiac tissues. Mol Endocrinol. 1991;5:1292-1300.
5. Nazario B, Hu R-M, Pedram A, Prins B, Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest. 1995;95:1151-1157.
6. Porter JG, Catalano R, McEnroe G, Lewicki JA, Protter AA. C-type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992;263: C1001-C1006.
7. Furuya M, Aisaka K, Miyazaki T, Honbou N, Kawishima K, Ohno T, Tanaka S, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide inhibits intimai thickening after vascular injury. Biochem Biophys Res Commun. 1993;193:248-253.
8. Seilhamer JJ, Arfsten A, Miller JA, Lundquist P, Scarborough RM, Lewicki JA, Porter JG. Human and canine gene homologs of porcine brain natriuretic peptide. Biochem Biophys Res Commun. 1989;165:650-658.
9. Wu J, Kovacic-Milivojevic B, LaPointe MC, Nakamura K, Gardner DG. Cis-active determinants of cardiac-specific expression in the human atrial natriuretic peptide gene. Mol Endocrinol. 1991;5: 1311-1322.
10. Webb P, Lopez GN, Uht RM, Kushner PJ. Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol. 1995; 9:443-456.
11. Thuerauf DJ, Hanford DS, Glembotski C. Regulation of rat brain natriuretic peptide gene. J Biol Chem. 1994;269:17772-17775.
12. Steinhelper ME. Structure, expression, and genomic mapping of the mouse natriuretic peptide type-B gene. Circ Res. 1993;72: 984-992.
13. Grepin C, Dagnino L, Robitaille, Haberstroh L, Antakly T, Nemer M. A hormone-encoding gene identifies a pathway for cardiac but not skeletal muscle gene transcription. Mol Cell Biol. 1994;14: 3115-3129.
14. Mukoyama M, Nakao K, Hosoda K, Suga S-I, Saito Y, Ogawa Y, Shirakami G, Jougasaki M, Obata K, Yasue H, Kambayashi Y, Inouye K, Imura H. Brain natriuretic peptide as a novel cardiac hormone in humans: evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest. 1991;87:1402-1412.
15. Gerbes AL, Dagnino L, Nguyen T, Nemer M. Transcription of brain natriuretic peptide and atrial natriuretic peptide genes in human tissues. J Clin Endocrinol Metab. 1994;78:1307-1311.
16. Hanford DS, Thuerauf DJ, Murray SF, Glembotski CC. Brain natriuretic peptide is induced by α-adrenergic agonists as a primary response gene in cultured rat cardiac myocytes. J Biol Chem. 1994; 269:26227-26233.
17. Olson EN. Regulatory mechanisms for skeletal muscle differentiation and their relevance to gene expression in the heart. Trends Cardiovasc Med. 1992;2:163-170.
18. Buckingham M. Molecular biology of muscle development. Cell. 1994;78:15-21.
19. Shimizu N, Smith G, Izumo S. Both a ubiquitous factor mTEF-1 and a distinct muscle-specific factor bind to the M-CAT motif of the myosin heavy chain β gene. Nucleic Acids Res. 1993;21:4103-4110.
20. Kariya K-I, Karns LR, Simpson PC. An enhancer core element mediates stimulation of the rat β-myosin heavy chain promoter by an α1-adrenergic agonist and activated β-protein kinase C in hypertrophy of cardiac myocytes. J Biol Chem. 1994;269:3775-3782.
21. Farrance IKG, Mar JH, Ordahl CP. M-CAT binding factor is related to the SV40 enhancer binding factor, TEF-1. J Biol Chem. 1992;267:17234-17240.
22. Molkentin JD, Kalvakolanu DV, Markham BE. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the α-myosin heavy chain gene. Mol Cell Biol. 1994;14:4947-4957.
23. Kitsis RN, Buttrick PM, McNally EM, Kaplan ML, Leinwand LA. Hormonal modulation of a gene injected into rat heart in vivo. Proc Natl Acad Sci U S A. 1991;88:4138-4142.
24. Ojamaa K, Petrie JF, Balkman C, Hong C, Klein I. Posttranscriptional modification of myosin heavy-chain gene expression in the hypertrophied rat myocardium. Proc Natl Acad Sci U S A. 1994;91: 3468-3472.
25. Vincent CK, Gualberto A, Patel CV, Walsh K. Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol. 1993;13: 1264-1272.
26. Parmacek MS, Vora AJ, Shen T, Barr E, Jung F, Leiden J. Identification and characterization of a cardiac-specific transcriptional regulatory element in the slow/cardiac troponin C gene. Mol Cell Biol. 1992;12:1967-1976.